Mylan may sweeten terms for Perrigo deal

Pharma group chairman told investors he may sweeten the company’s offer for Irish headquartered company by adding terms to reduce the risk to its shareholders




The Counter Ruck

The Counter Ruck

Sign up to the Irish Times weekly rugby digest for the view from the press box with Gerry Thornley


YOU MAY ALSO LIKE...

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands